View in EDS PDF Full Text

Cell-based therapy in prophylaxis and treatment of chronic graft-versus-host disease.

Saved in:
Bibliographic Details
Title: Cell-based therapy in prophylaxis and treatment of chronic graft-versus-host disease.
Authors: Doglio M; Experimental Haematology Unit, Division of Immunology Transplantation and Infectious Diseases, Vita-Salute San Raffaele University, Milan, Italy., Crossland RE; Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom., Alho AC; JLacerda Lab, Hematology and Transplantation Immunology, Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal.; Serviço de Hematologia e Transplantação de Medula, Hospital de Santa Maria, Centro Hospitalar Universitário de Lisboa Norte, Lisbon, Portugal., Penack O; Department of Hematology, Oncology, and Cancer Immunology, Charité Universitätsmedizin Berlin, Berlin, Germany., Dickinson AM; Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom.; Alcyomics Ltd, Newcastle upon Tyne, United Kingdom., Stary G; Department of Dermatology, Medical University of Vienna, Vienna, Austria.; Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases, Vienna, Austria.; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria., Lacerda JF; JLacerda Lab, Hematology and Transplantation Immunology, Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal.; Serviço de Hematologia e Transplantação de Medula, Hospital de Santa Maria, Centro Hospitalar Universitário de Lisboa Norte, Lisbon, Portugal., Eissner G; Systems Biology Ireland, School of Medicine, Conway Institute, University College Dublin, Dublin, Ireland., Inngjerdingen M; Department of Pharmacology, University of Oslo and Oslo University Hospital, Oslo, Norway.
Source: Frontiers in immunology [Front Immunol] 2022 Nov 17; Vol. 13, pp. 1045168. Date of Electronic Publication: 2022 Nov 17 (Print Publication: 2022).
Publication Type: Journal Article; Review; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36466922
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Cell-based therapy in prophylaxis and treatment of chronic graft-versus-host disease.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Doglio+M%22">Doglio M</searchLink>; Experimental Haematology Unit, Division of Immunology Transplantation and Infectious Diseases, Vita-Salute San Raffaele University, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Crossland+RE%22">Crossland RE</searchLink>; Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Alho+AC%22">Alho AC</searchLink>; JLacerda Lab, Hematology and Transplantation Immunology, Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal.; Serviço de Hematologia e Transplantação de Medula, Hospital de Santa Maria, Centro Hospitalar Universitário de Lisboa Norte, Lisbon, Portugal.<br /><searchLink fieldCode="AU" term="%22Penack+O%22">Penack O</searchLink>; Department of Hematology, Oncology, and Cancer Immunology, Charité Universitätsmedizin Berlin, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Dickinson+AM%22">Dickinson AM</searchLink>; Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom.; Alcyomics Ltd, Newcastle upon Tyne, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Stary+G%22">Stary G</searchLink>; Department of Dermatology, Medical University of Vienna, Vienna, Austria.; Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases, Vienna, Austria.; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Lacerda+JF%22">Lacerda JF</searchLink>; JLacerda Lab, Hematology and Transplantation Immunology, Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal.; Serviço de Hematologia e Transplantação de Medula, Hospital de Santa Maria, Centro Hospitalar Universitário de Lisboa Norte, Lisbon, Portugal.<br /><searchLink fieldCode="AU" term="%22Eissner+G%22">Eissner G</searchLink>; Systems Biology Ireland, School of Medicine, Conway Institute, University College Dublin, Dublin, Ireland.<br /><searchLink fieldCode="AU" term="%22Inngjerdingen+M%22">Inngjerdingen M</searchLink>; Department of Pharmacology, University of Oslo and Oslo University Hospital, Oslo, Norway.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2022 Nov 17; Vol. 13, pp. 1045168. <i>Date of Electronic Publication: </i>2022 Nov 17 (<i>Print Publication: </i>2022).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36466922
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fimmu.2022.1045168
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1045168
    Titles:
      – TitleFull: Cell-based therapy in prophylaxis and treatment of chronic graft-versus-host disease.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Doglio M
      – PersonEntity:
          Name:
            NameFull: Crossland RE
      – PersonEntity:
          Name:
            NameFull: Alho AC
      – PersonEntity:
          Name:
            NameFull: Penack O
      – PersonEntity:
          Name:
            NameFull: Dickinson AM
      – PersonEntity:
          Name:
            NameFull: Stary G
      – PersonEntity:
          Name:
            NameFull: Lacerda JF
      – PersonEntity:
          Name:
            NameFull: Eissner G
      – PersonEntity:
          Name:
            NameFull: Inngjerdingen M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 17
              M: 11
              Text: 2022 Nov 17
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1664-3224
          Numbering:
            – Type: volume
              Value: 13
          Titles:
            – TitleFull: Frontiers in immunology
              Type: main
ResultId 1